Table 3.
Percentages of correct responses of nursing students to questions on knowledge regarding Vipera palaestinae.
| Question | Number (%) |
|---|---|
| The most common venomous snake in Palestine is Vipera palaestinae (T) | 151 (75.5) |
| The venom of Vipera palaestinae contains the neurotoxic compound (T) | 134 (67.5) |
| Local swelling is the most common clinical symptom of envenomation (T) | 105 (52.5) |
| Its length is 1 meter on average (T) | 104 (52) |
| The venom of Vipera palaestinae contains a hemorrhagic compound (T) | 95 (47.5) |
| The venom of Vipera palaestinae contains integrin inhibitors compound (T) | 90 (45) |
| The venom of Vipera palaestinae contains growth factors inhibitors compound (T) | 64 (32) |
| Males are bitten twice as often as females (T) | 61 (30.5) |
| The mortality rate is 1.5% due to the envenomation of Vipera palaestinae (T) | 47 (23.5) |
| The total level of serum cholesterol in admission can serve as an indicator of the severity of envenomation (T) | 33 (16.5) |
| Envenomation was reported only in humans (F) | 31 (15.5) |
| The venom of Vipera palaestinae contains cardiotoxin compound (T) | 18 (9) |
| Increased body temperature is the most common clinical symptom of envenomation (F) | 17 (8.5) |
These questions were adapted from a previous study [33].